FORM C |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Form C: Filer Information
Filer CIK: | 0001787792 |
Filer CCC: | XXXXXXXX |
Period: | 12-31-2022 |
Is this a LIVE or TEST Filing? | LIVE TEST |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
Would you like a Return Copy? |
Submission Contact Information
Name: | |
Phone Number: | |
Contact E-Mail Address: | |
Notify via Filing Website only? |
Form C: Issuer Information
Issuer Information
Name of Issuer: | Fisher Wallace Laboratories Inc. |
Legal Status of Issuer:
Form: | Corporation |
Jurisdiction of Incorporation/Organization: |
DELAWARE
|
Date of Incorporation/Organization: | 08-23-2019 |
Physical Address of Issuer:
Address 1: | 630 Flushing Avenue, Suite #104 |
City: | Brooklyn |
State/Country: |
NEW YORK
|
Mailing Zip/Postal Code: | 11206 |
Website of Issuer: | www.fisherwallace.com |
Form C: Annual Report Disclosure Requirements
Annual Report Disclosure Requirements
Current Number of Employees: | 12 |
Total Assets Most Recent Fiscal Year-end: | 439495.00 |
Total Assets Prior Fiscal Year-end: | 1999403.00 |
Cash and Cash Equivalents Most Recent Fiscal Year-end: | 128229.00 |
Cash and Cash Equivalents Prior Fiscal Year-end: | 1929380.00 |
Accounts Receivable Most Recent Fiscal Year-end: | 0.00 |
Accounts Receivable Prior Fiscal Year-end: | 0.00 |
Short-term Debt Most Recent Fiscal Year-end: | 3580346.00 |
Short-term Debt Prior Fiscal Year-end: | 966198.00 |
Long-term Debt Most Recent Fiscal Year-end: | 1083664.00 |
Long-term Debt Prior Fiscal Year-end: | 576525.00 |
Revenue/Sales Most Recent Fiscal Year-end: | 4739387.00 |
Revenue/Sales Prior Fiscal Year-end: | 4230290.00 |
Cost of Goods Sold Most Recent Fiscal Year-end: | 1096113.00 |
Cost of Goods Sold Prior Fiscal Year-end: | 623703.00 |
Taxes Paid Most Recent Fiscal Year-end: | 0.00 |
Taxes Paid Prior Fiscal Year-end: | 250.00 |
Net Income Most Recent Fiscal Year-end: | -7073744.00 |
Net Income Prior Fiscal Year-end: | -3262291.00 |
Form C: Signature
Signature
Issuer: | Fisher Wallace Laboratories, Inc. |
Signature: | Kelly Roman |
Title: | CEO |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Charles Fisher |
Title: | Founder, CFO |
Date: | 05-02-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Simon Webster |
Title: | Director |
Date: | 05-02-2023 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Kelly Roman |
Title: | CEO |
Date: | 05-02-2023 |